Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

Oruka Therapeutics (ORKA)

Oruka Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ORKA
DateTimeSourceHeadlineSymbolCompany
05/02/202521:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ORKAOruka Therapeutics Inc
24/01/202521:44Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ORKAOruka Therapeutics Inc
24/01/202521:43Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ORKAOruka Therapeutics Inc
24/01/202521:42Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ORKAOruka Therapeutics Inc
24/01/202521:41Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ORKAOruka Therapeutics Inc
19/12/202412:16Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ORKAOruka Therapeutics Inc
19/12/202412:00GlobeNewswire Inc.Oruka Therapeutics Announces First Participants Dosed in Phase 1 Trial of ORKA-001, its Novel Half-life Extended Anti-IL-23p19 AntibodyNASDAQ:ORKAOruka Therapeutics Inc
18/12/202412:00GlobeNewswire Inc.Oruka Therapeutics to be Added to the Nasdaq Biotechnology Index (NBI)NASDAQ:ORKAOruka Therapeutics Inc
27/11/202405:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ORKAOruka Therapeutics Inc
21/11/202423:30Edgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:ORKAOruka Therapeutics Inc
21/11/202423:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ORKAOruka Therapeutics Inc
19/11/202413:00GlobeNewswire Inc.Oruka Therapeutics to Present at Piper Sandler’s 36th Annual Healthcare ConferenceNASDAQ:ORKAOruka Therapeutics Inc
18/11/202421:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ORKAOruka Therapeutics Inc
15/11/202400:38Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:ORKAOruka Therapeutics Inc
14/11/202422:49Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:ORKAOruka Therapeutics Inc
14/11/202422:20Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:ORKAOruka Therapeutics Inc
14/11/202421:56Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ORKAOruka Therapeutics Inc
14/11/202417:04Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:ORKAOruka Therapeutics Inc
14/11/202414:56Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:ORKAOruka Therapeutics Inc
14/11/202411:37Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:ORKAOruka Therapeutics Inc
13/11/202421:25GlobeNewswire Inc.Oruka Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:ORKAOruka Therapeutics Inc
13/11/202421:01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ORKAOruka Therapeutics Inc
04/11/202412:00GlobeNewswire Inc.Oruka Therapeutics to Present at Multiple November Investor ConferencesNASDAQ:ORKAOruka Therapeutics Inc
22/10/202420:15Edgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:ORKAOruka Therapeutics Inc
18/10/202420:11Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:ORKAOruka Therapeutics Inc
04/10/202420:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ORKAOruka Therapeutics Inc
25/09/202411:08GlobeNewswire Inc.Oruka Therapeutics Announces Preclinical Data for ORKA-001 at the European Academy of Dermatology and Venereology CongressNASDAQ:ORKAOruka Therapeutics Inc
13/09/202420:57Edgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:ORKAOruka Therapeutics Inc
13/09/202420:55Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ORKAOruka Therapeutics Inc
13/09/202420:02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ORKAOruka Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:ORKA

Your Recent History

Delayed Upgrade Clock